Can Blood Transfusion Be Done While Albumin Infusion Is Going On?
Yes, blood transfusion can be safely administered concurrently with albumin infusion, as albumin is explicitly compatible with whole blood and packed red blood cells.
Compatibility Evidence
The FDA-approved albumin drug label clearly states that albumin "is compatible with whole blood, packed red cells, as well as the standard carbohydrate and electrolyte solutions intended for intravenous use" 1. This direct compatibility statement from the regulatory authority provides the strongest evidence for concurrent administration.
Important Administration Guidelines
What Can Be Mixed:
- Whole blood - fully compatible
- Packed red blood cells - fully compatible
- Standard carbohydrate solutions
- Standard electrolyte solutions
What Should NOT Be Mixed:
The albumin should not be mixed in the same line with 1:
- Protein hydrolysates
- Amino acid solutions
- Solutions containing alcohol
Clinical Considerations for Concurrent Use
Monitor for Hemodilution
When administering albumin alongside blood transfusions, be aware that:
- Albumin causes significant hemodilution that can decrease hemoglobin concentration by approximately 5 g/L on average 2
- With isooncotic albumin (5%, 25g in 500 mL), hemoglobin may drop by more than 8 g/L 2
- This hemodilution effect persists for at least 12 hours after albumin administration 2
- The dilutional effect may trigger additional transfusion needs if hemoglobin falls below your institutional threshold 2
Timing Strategy
While concurrent administration is safe, consider the sequence:
- In hemorrhage, albumin administration should be supplemented by whole blood transfusion to treat the relative anemia from hemodilution 1
- The hyperoncotic effect of 25% albumin draws approximately 70 mL of additional fluid into circulation within 15 minutes 1, which will further dilute hemoglobin
Volume Status Monitoring
- Patients must be monitored carefully for circulatory overload when both products are given 1
- In dehydrated patients, albumin must be given with or followed by additional fluids 1
- The rapid rise in blood pressure from albumin's oncotic activity requires vigilant monitoring 1
Practical Approach
Use separate IV lines for albumin and blood products to avoid any mixing of incompatible additives that might be present in either solution, even though the products themselves are compatible.
Anticipate increased transfusion requirements: Patients receiving albumin, especially the isooncotic formulation, may require more RBC transfusions due to hemodilution 2. This is particularly relevant in surgical patients where albumin use has increased substantially (from 4.7% to 47.2% in surgical ICU patients) 2.